Cargando…
Protocol for Evaluating In Vivo the Activation of the P2RX7 Immunomodulator
BACKGROUND: P2RX7 is a purinergic receptor with pleiotropic activities that is activated by high levels of extracellular ATP that are found in inflamed tissues. P2RX7 has immunomodulatory and anti-tumor proprieties and is therefore a therapeutic target for various diseases. Several compounds are dev...
Autores principales: | Janho dit Hreich, Serena, Juhel, Thierry, Hofman, Paul, Vouret-Craviari, Valérie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811721/ https://www.ncbi.nlm.nih.gov/pubmed/36600200 http://dx.doi.org/10.1186/s12575-022-00188-6 |
Ejemplares similares
-
The Role of IL-18 in P2RX7-Mediated Antitumor Immunity
por: Janho dit Hreich, Serena, et al.
Publicado: (2023) -
Alternative splicing of P2RX7 pre-messenger RNA in health and diseases: Myth or reality?
por: Benzaquen, Jonathan, et al.
Publicado: (2019) -
P2RX7B is a new theranostic marker for lung adenocarcinoma patients
por: Benzaquen, Jonathan, et al.
Publicado: (2020) -
The Purinergic Landscape of Non-Small Cell Lung Cancer
por: Janho dit Hreich, Serena, et al.
Publicado: (2022) -
A small-molecule P2RX7 activator promotes anti-tumor immune responses and sensitizes lung tumor to immunotherapy
por: Douguet, Laetitia, et al.
Publicado: (2021)